News
19 February 2018
Our CEO, Gurutz Linazasoro, interviewed by Diario Vasco
Our CEO was interviewed by Diario Vasco and confirmed that VIVEbiotech is immersed in a capital increase to multiply its capacity tenfold and meet much...
Read more)
15 February 2018
The General Representative of Gipuzkoa, Markel Olano, and the Representative for Economic Promotion, Ainhoa Aizpuru, visited VIVEbiotech today
The General Representative of Gipuzkoa, Markel Olano, and the Representative for Economic Promotion. Ainhoa Aizpuru, visited VIVEbiotech today to see first hand the contribution that...
Read more12 February 2018
New concession of the Seal of Excellence by the European Union
VIVEbiotech has been awarded again with the Seal of Excellence by the European Union with the project entitled “Safeguarding gene therapy: LENTISOMA an innovative safEfficient...
Read more22 January 2018
Publication of VIVEbiotech in “Estrategia Empresarial”
The biweekly newspaper "Estrategia Empresarial" has published a new on its Inno-Tech section on the occasion of the visit of the Health Minister of the...
Read more)
17 January 2018
VIVEbiotech has received the visit of the Deputy Minister of Technology, Innovation and Competitiveness, and the Director of Technology and Strategy of the Basque Government
VIVEbiotech has received the visit of Estíbaliz Hernáez and Iosu Madariaga, Deputy Minister of Technology, Innovation and Competitiveness, and Director of Technology and...
Read more)
15 January 2018
The Regional Minister of Health of the Basque Government visits VIVEbiotech
The Regional Minister of Health of the Basque Government, Jon Darpón, the Deputy Minister of Health, Iñaki Berraondo, and the Director of Health...
Read more3 January 2018
Events for first part of 2018
New year 2018 has finally arrived and VIVEbiotech´s team is already preparing its attendance to different congresses to continue spreading its international presence.
Read more)
24 November 2017
VIVEbiotech´s participation in the XV International Conference of Scientific and Technological Parks
Our CSO/CTO, Juan Carlos Ramirez, gave an oral presentation under the theme line “ Beyond 2020: Disruptive technologies”.
Read more19 November 2017
VIVEbiotech´s new publication: “Gene Editing and CRISPR Therapeutics: Strategies Taught by Cell and Gene Therapy”
Juan Carlos Ramirez, VIVEbiotech´s CSO/CTO, has just published a new paper entitled “Gene Editing and CRISPR Therapeutics: Strategies Taught by Cell and Gene...
Read more)
9 November 2017
VIVEbiotech attended the biggest biotech event in Europe: BioEurope 2017
VIVEbiotech´s exhibited at BioEurope 2017 event, the most relevant event in the Biotechnology field in Europe that took place in Berlin from the 5th to...
Read moreDestacadas
)
)
)
)
){kind=spacer}
4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
)
)
14 February 2024
VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024
)
)
9 February 2024
)